ChasingTheMoon

CUE PHARAM - 70% GAINS

Long
NASDAQ:CUE   Cue Biopharma, Inc
- Inverse head and shoulders pattern playing out on the trendline support
- Tipranks analyst consensus $31 Target of 121% upside
- Recent insider purchases, always a good sign
- CUE-101 Phase one is looking very promising